Friday, September 4, 2026
22.3 C
Bengaluru

Interview with Salil Kallianpur

[wpfilebase tag=file id=95 tpl=download-button /]

Inside this Issue

1. Interview with Salil Kallianpur  with Anup Soans, Editor – MedicinMan

“There is much work to be done and a unified pharma industry can prove to be a valuable ally to the government.”

2. Patient-centricity: How Pharma Can Move from Intention to Action by Hanno Wolfram

Patient-centricity begins with moving from talking about the patient to talking to the patient 

3. The Corporate Halo Effect by Vivek Hattangadi

How a great corporate brand elevates a company’s products in the minds of doctors and patients

4. For a Positive Attitude, Clean Your Mind’s Windows  by Asheesh Kumar Patel

A bad attitude is a learned behavior and can be unlearned when we discover it’s source

5. The Three Transformations for Leadership  by Srinivasan Athmanathan

Three key professional traits that every successful leader must possess

6. Book Review: Feather in a C.A.P. by Kamalesh Subramanian 

A corporate saga with valuable lessons for professionals of all backgrounds

Hot this week

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

Topics

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...
spot_img

Related Articles

spot_imgspot_img